{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:38:21Z","timestamp":1774611501740,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,12,12]],"date-time":"2009-12-12T00:00:00Z","timestamp":1260576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1007\/s00296-009-1288-6","type":"journal-article","created":{"date-parts":[[2009,12,11]],"date-time":"2009-12-11T05:56:51Z","timestamp":1260511011000},"page":"201-208","source":"Crossref","is-referenced-by-count":9,"title":["Autoantibodies against oxidized low-density lipoprotein and lipid profile in patients with chronic periaortitis: case\u2013control study"],"prefix":"10.1007","volume":"31","author":[{"given":"E. F. H.","family":"van Bommel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L. J. H.","family":"van Tits","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. A.","family":"van den Berg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Prins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. F. H.","family":"Stalenhoef","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,12]]},"reference":[{"key":"1288_CR1","first-page":"784","volume":"110","author":"MJ Mitchinson","year":"1986","unstructured":"Mitchinson MJ (1986) Retroperitoneal fibrosis revisited. Arch Pathol Lab Med 110:784\u2013786","journal-title":"Arch Pathol Lab Med"},{"key":"1288_CR2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2559.1990.tb01541.x","volume":"16","author":"DV Parums","year":"1990","unstructured":"Parums DV (1990) The spectrum of chronic periaortitis. Histopathology 16:423\u2013431","journal-title":"Histopathology"},{"key":"1288_CR3","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1464-410X.1991.tb15216.x","volume":"67","author":"DV Parums","year":"1991","unstructured":"Parums DV, Choudhury RP, Shields SA, Davies AH (1991) Characterisation of inflammatory cells associated with \u2018idiopathic retroperitoneal fibrosis\u2019. Br J Urol 67:564\u2013568","journal-title":"Br J Urol"},{"key":"1288_CR4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0021-9150(86)90070-5","volume":"61","author":"DV Parums","year":"1986","unstructured":"Parums DV, Chadwick DR, Mitchinson MJ (1986) The localisation of immunoglobulin in chronic periaortitis. Atherosclerosis 61:117\u2013123","journal-title":"Atherosclerosis"},{"key":"1288_CR5","first-page":"383","volume":"114","author":"DV Parums","year":"1990","unstructured":"Parums DV, Brown DL, Mitchinson MJ (1990) Serum antibodies to oxidized low-density lipoprotein and ceroid in chronic periaortitis. Arch Pathol Lab Med 114:383\u2013387","journal-title":"Arch Pathol Lab Med"},{"key":"1288_CR6","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1136\/bmj.297.6643.240","volume":"297","author":"N Bullock","year":"1988","unstructured":"Bullock N (1988) Idiopathic retroperitoneal fibrosis. BMJ 297:240\u2013241","journal-title":"BMJ"},{"key":"1288_CR7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1046\/j.1464-410X.2003.04483.x","volume":"92","author":"LRI Baker","year":"2003","unstructured":"Baker LRI (2003) Auto-allergic periaortitis (idiopathic retroperitoneal fibrosis). BJU 92:663\u2013665","journal-title":"BJU"},{"key":"1288_CR8","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1159\/000097015","volume":"105","author":"P Meier","year":"2007","unstructured":"Meier P, Vogt B, Blanc E (2007) Rethinking the triggering inflammatory processes of chronic periaortitis. Nephron Exp Nephrol 105:e17\u2013e23","journal-title":"Nephron Exp Nephrol"},{"key":"1288_CR9","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0741-5214(03)00340-9","volume":"38","author":"ES Haug","year":"2003","unstructured":"Haug ES, Skomsvoll JF, Jacobsen G, Halvorsen TB, Saether OD, Myhre HO (2003) Inflammatory aortic aneurysm is associated with increased incidence of autoimmune disease. J Vasc Surg 38:492\u2013497","journal-title":"J Vasc Surg"},{"key":"1288_CR10","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0002-9343(03)00056-1","volume":"114","author":"A Vaglio","year":"2003","unstructured":"Vaglio A, Corradi D, Manenti L, Ferretti S, Garini G, Buzio C (2003) Evidence of autoimmunity in chronic periaortitis: a prospective study. Am J Med 114:454\u2013462","journal-title":"Am J Med"},{"key":"1288_CR11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev.immunol.021908.132620","volume":"27","author":"E Galkina","year":"2009","unstructured":"Galkina E, Ley K (2009) Immune and inflammatory mechanisms of atherosclerosis. Annu Rev Immunol 27:165\u2013197","journal-title":"Annu Rev Immunol"},{"key":"1288_CR12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/1358863X08091147","volume":"13","author":"EFH Bommel Van","year":"2008","unstructured":"Van Bommel EFH, van der Veer SJ, Hendriksz TR, Bleumink GS (2008) Persistent chronic periaortitis (\u2018inflammatory aneurysm\u2019) after abdominal aortic aneurysm repair: systematic review of the literature. Vasc Med 13:293\u2013303","journal-title":"Vasc Med"},{"key":"1288_CR13","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7326\/0003-4819-144-2-200601170-00007","volume":"144","author":"Van Bommel","year":"2006","unstructured":"Bommel Van, Hendriksz TR, Huiskes AW, Zeegers AG (2006) Brief communication: tamoxifen therapy for idiopathic retroperitoneal fibrosis. Ann Intern Med 144:101\u2013106","journal-title":"Ann Intern Med"},{"key":"1288_CR14","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1053\/j.ajkd.2007.02.268","volume":"49","author":"EF Bommel Van","year":"2007","unstructured":"Van Bommel EF, Siemes C, Hak LE, van der Veer SJ, Hendriksz TR (2007) Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am J Kidney Dis 49:615\u2013625","journal-title":"Am J Kidney Dis"},{"key":"1288_CR15","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/S0891-5849(01)00519-6","volume":"30","author":"LJH Tits van","year":"2001","unstructured":"van Tits LJH, de Waart F, Hak-Lemmers HLM (2001) Effects of alfa-Tocopherol on superoxide production and plasma intercellular adhesion molecule-1 and antibodies to oxidized LDL in chronic smokers. Free Radical Biol Med 30:1122\u20131129","journal-title":"Free Radical Biol Med"},{"key":"1288_CR16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1128\/CDLI.10.4.499-505.2003","volume":"10","author":"G Virella","year":"2003","unstructured":"Virella G, Lopes-Virella MF (2003) Lipoprotein autoantibodies: measurement and significance. Clin Diagn Lab Immunol 10:499\u2013505","journal-title":"Clin Diagn Lab Immunol"},{"issue":"17","key":"1288_CR17","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1161\/01.CIR.0000143225.07377.EA","volume":"110","author":"Y Shoenfeld","year":"2004","unstructured":"Shoenfeld Y, Wu R, Dearing LD, Matsuura E (2004) Are anti-oxidized low-density lipoprotein antibodies pathogenic or protective? Circulation 110(17):2552\u20132558","journal-title":"Circulation"},{"key":"1288_CR18","doi-asserted-by":"crossref","first-page":"C19","DOI":"10.1016\/j.jacc.2005.10.066","volume":"47","author":"S Tsimikas","year":"2006","unstructured":"Tsimikas S, Willerson JT, Ridker PM (2006) C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. J Am Coll Cardiol 47:C19\u2013C31","journal-title":"J Am Coll Cardiol"},{"key":"1288_CR19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/MD.0b013e3181afc420","volume":"88","author":"EFH Bommel Van","year":"2009","unstructured":"Van Bommel EFH, Jansen I, Hendriksz TR, Aarnoudse ALHJ (2009) Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiological presentation. Medicine 88:193\u2013201","journal-title":"Medicine"},{"key":"1288_CR20","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1046\/j.1538-7836.2003.00392.x","volume":"1","author":"B Bonanni","year":"2003","unstructured":"Bonanni B, Johansson H, Gandini S et al (2003) Effect of tamoxifen at low doses on ultrasensitive C-reactive protein in healthy women. J Thromb Haemost 1:2149\u20132152","journal-title":"J Thromb Haemost"},{"key":"1288_CR21","first-page":"1165","volume":"308","author":"P Medina De","year":"2004","unstructured":"De Medina P, Payre BL, Bernad J et al (2004) Tamoxifen is a potent inhibitor of cholesterol esterification and prevents the formation of foam cells. J Pharmacol 308:1165\u20131173","journal-title":"J Pharmacol"},{"key":"1288_CR22","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1161\/CIRCULATIONAHA.104.531178","volume":"112","author":"DJ Grainger","year":"2005","unstructured":"Grainger DJ, Schofield PM (2005) Tamoxifen for the prevention of mycardial infarction in humans: preclinical and clinical evidence. Circulation 112:3018\u20133024","journal-title":"Circulation"},{"key":"1288_CR23","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1194\/jlr.M400290-JLR200","volume":"46","author":"FJ Tinahones","year":"2005","unstructured":"Tinahones FJ, Gomez-Zumaquero JM, Garrido-Sanchez L et al (2005) Influence of age and sex on levels of anti-oxidized LDL antibodies and anti-LDL immune complexes in the general population. J Lipid Res 46:452\u2013457","journal-title":"J Lipid Res"},{"key":"1288_CR24","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/rheumatology\/keh109","volume":"43","author":"JM Gomez-Zumaquero","year":"2004","unstructured":"Gomez-Zumaquero JM, Tinahones FJ, de Ram\u00f3n E, Camps M, Garrido L, Soriguer FJ (2004) Association of biological markers of activity of lupus erythematosus with levels of anti-oxidized low-density lipoprotein antibodies. Rheumatology 43:510\u2013513","journal-title":"Rheumatology"},{"key":"1288_CR25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cccn.2003.09.019","volume":"339","author":"Z Tsutsumi","year":"2004","unstructured":"Tsutsumi Z, Moriwaki Y, Takahashi S, Ka T, Yamamoto T (2004) Oxidized low-density lipoprotein autoantibodies in patients with primary gout: effect of urate-lowering therapy. Clin Chim Acta 339:117\u2013122","journal-title":"Clin Chim Acta"},{"key":"1288_CR26","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/ard.52.9.677","volume":"52","author":"PG Winyard","year":"1993","unstructured":"Winyard PG, Tatzber F, Esterbauer H, Kus ML, Blake DR, Morris CJ (1993) Presence of foam cells containing oxidised low density lipoprotein in the synovial membrane from patient with rheumatoid arthritis. Ann Rheum Dis 52:677\u2013680","journal-title":"Ann Rheum Dis"},{"key":"1288_CR27","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1042\/CS20010098","volume":"101","author":"A Dotevall","year":"2001","unstructured":"Dotevall A, Hulthe J, Rosengren A, Wiklund O, Wilhelmsen L (2001) Autoantibodies against oxidized low-density lipoprotein and C-reactive protein are associated with diabetes and myocardial infarction in women. Clin Sci 101:523\u2013531","journal-title":"Clin Sci"},{"key":"1288_CR28","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.atherosclerosis.2005.10.017","volume":"188","author":"SJ Georgiades","year":"2006","unstructured":"Georgiades SJ, Wu R, Thulin T, Frostegard J (2006) Antibodies of IgM subclass to phosphorycholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension. Atherosclerosis 188:160\u2013166","journal-title":"Atherosclerosis"},{"key":"1288_CR29","doi-asserted-by":"crossref","unstructured":"Orchard TJ, Virella G, Forrest KY, Evans RW, Becker DJ, Lopes-Virella MF (1999) Antibodies to oxidized LDL predict coronary artery disease in type 1 diabetes: a nested case-control study from the Pittsburgh Epidemiology of Diabetes Complications Study. Diabetes 48(7):1454\u20131458","DOI":"10.2337\/diabetes.48.7.1454"},{"key":"1288_CR30","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.atherosclerosis.2005.06.006","volume":"185","author":"LHJ Tits Van","year":"2006","unstructured":"Van Tits LHJ, Himbergen TM, Lemmers HLM, de Graaf J, Stalenhoef AFH (2006) Proportion of oxidized LDL relative to plasma apolipoprotein B does not change during statin therapy in patients with heterozygous familial hypercholesterolemia. Atherosclerosis 185:307\u2013312","journal-title":"Atherosclerosis"},{"key":"1288_CR31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.LAB.0000048633.76607.E0","volume":"83","author":"LHJ Tits Van","year":"2003","unstructured":"Van Tits LHJ, De Graaf J, Hak-Lemmers H, Bredie S, Demacker P, Holvoet P, Stalenhoef AFH (2003) Increased levels of low-density lipoprotein oxidation in patients with familial hypercholesterolemia and in end-stage renal disease patients on hemodialysis. Lab Invest 83:13\u201321","journal-title":"Lab Invest"},{"key":"1288_CR32","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-2249.2001.01488.x","volume":"124","author":"BP Swets","year":"2001","unstructured":"Swets BP, Brouwer DAJ, Cohen Tervaert JW (2001) Patients with systemic vasculitis have increased levels of autoantibodies against oxidized LDL. Clin Exp Immunol 124:163\u2013167","journal-title":"Clin Exp Immunol"},{"key":"1288_CR33","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0378-5122(98)00002-4","volume":"29","author":"AM Heikkinen","year":"1998","unstructured":"Heikkinen AM, Niskanen L, Yl\u00e4-Herttuala S et al (1998) Postmenopausal hormone replacement therapy and autoantibodies against oxidized LDL. Maturitas 29:155\u2013161","journal-title":"Maturitas"},{"key":"1288_CR34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/07315724.2002.10719231","volume":"21","author":"I Bureau","year":"2002","unstructured":"Bureau I, Laporte F, Favier M et al (2002) No antioxidant effect of combined HRT on LDL oxidizability and oxidative stress biomarkers in treated post-menopausal women. J Am Coll Nutr 21:333\u2013338","journal-title":"J Am Coll Nutr"},{"key":"1288_CR35","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S0026-0495(98)90029-4","volume":"47","author":"N Hoogerbrugge","year":"1998","unstructured":"Hoogerbrugge N, Zillekens MC, Jansen H et al (1998) Estrogen replacement decreased the levels of antibodies against oxidized low density lipoprotein in postmenopausal women with coronary heart disease. Metabolism 47:675\u2013680","journal-title":"Metabolism"},{"key":"1288_CR36","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1590\/S0100-879X2003000400011","volume":"36","author":"L Uint","year":"2003","unstructured":"Uint L, Gebara OCE, Pinto LB et al (2003) Hormone replacement therapy increases levels of antibodies against heat shock protein 65 and certain species of oxidized low density lipoprotein. Braz J Med Biol Res 36:491\u2013494","journal-title":"Braz J Med Biol Res"},{"key":"1288_CR37","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1161\/CIRCULATIONAHA.104.529297","volume":"112","author":"C Meisinger","year":"2005","unstructured":"Meisinger C, Baumert J, Khuseyinova N, Loewel H, Koenig W (2005) Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population. Circulation 112:651\u2013657","journal-title":"Circulation"},{"key":"1288_CR38","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1161\/01.ATV.0000021150.63480.CD","volume":"22","author":"J Hulthe","year":"2002","unstructured":"Hulthe J, Fagerberg B (2002) Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR study). Arterioscler Thromb Vasc Biol 22:1162\u20131167","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1288_CR39","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0741-5214(96)70249-5","volume":"23","author":"SS Nitecki","year":"1996","unstructured":"Nitecki SS, Hallett JW, Stanson AW, Ilstrup DM, Bower TC, Cherry KJ, Gloviczki P, Pairolero PC (1996) Inflammatory abdominal aneurysms: a case-control study. J Vasc Surg 23:860\u2013869","journal-title":"J Vasc Surg"},{"key":"1288_CR40","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1042\/CS20030152","volume":"105","author":"J Frostegard","year":"2003","unstructured":"Frostegard J, Ruihua WU, Lemne C, Thulin T, Witzum JL, de Faires U (2003) Circulating oxidized low-density lipoprotein is increased in hypertension. Clin Sci 105:615\u2013620","journal-title":"Clin Sci"},{"key":"1288_CR41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1161\/01.ATV.15.4.441","volume":"15","author":"C Bergmark","year":"1995","unstructured":"Bergmark C, Wu R, de Faire U, Lefvert AK, Swedenborg J (1995) Patients with early-onset peripheral vascular disease have increased levels of autoantibodies against oxidized LDL. Arterioscler Thromb Vasc Biol 15:441\u2013445","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"1288_CR42","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/art.21698","volume":"55","author":"D Martorana","year":"2006","unstructured":"Martorana D, Vaglio A, Greco P, Zanetti A, Moroni G, Salvarani C, Savi M, Buzio C, Neri TM (2006) Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin. Arthritis Rheum 55:126\u2013130","journal-title":"Arthritis Rheum"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-1288-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00296-009-1288-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-009-1288-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T06:05:23Z","timestamp":1590300323000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00296-009-1288-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12,12]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["1288"],"URL":"https:\/\/doi.org\/10.1007\/s00296-009-1288-6","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,12,12]]}}}